Pitt, Martin - University of Exeter

研究领域

Within the field of health services research, Martin Pitt’s specific focus is on the application of operational research methods (e.g. modelling, simulation, and forecasting) and health economic cost-effectiveness analysis. Between 2003-2010, he work as part of PenTAG and developed cost-effectiveness models for use in health technology assessment for the National Institute of Health and Clinical Excellent (NICE). More recently, as Director of PenCHORD (Peninsula Collaboration for Health Operational Research and Development) he has led a wide range of initiatives in the application of these techniques across NHS trusts in Devon and Cornwall. Martin has a long standing interest in the effective implementation of research in health services and specifically in the use of visualisation techniques to improve the communication of research to key user groups. In 2004 he established MASHnet (the UK Modelling and Simulation in Healthcare Network) which aims to build links between health service, research and commercial sectors in order to improve understanding and effective implementation of these techniques for Service Delivery. In 2010 he was appointed Director of PenCHORD (www.penchord.org) which has been successful in developing a wide range of effective modelling projects with health service trusts in Devon and Cornwall. This work has resulted in publications in high impact journals (see publications below). Within PenCHORD, Martin now manages a team of five researchers (with two more appointments pending) and led on a number of successful grant initiatives (see below) and has organised and presented his work at major national and international events.

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Pitt M, Monks T, Crowe S, Vasilakis C (2016). Systems modelling and simulation in health service design, delivery and decision making. BMJ Qual Saf, 25(1), 38-45. Abstract. Author URL. Article has an altmetric score of 12 Monks T, Pearson M, Pitt M, Stein K, James MA (2015). Evaluating the impact of a simulation study in emergency stroke care. Operations Research for Health Care, 6, 40-49. Abstract. Full text. Article has an altmetric score of 10 Chalk D, Pitt M (2015). Fractured neck of femur patients: Rehabilitation and the acute hospital. British Journal of Health Care Management, 21(3), 146-151. Abstract. Allen M, Spencer A, Gibson A, Matthews J, Allwood A, Prosser S, Pitt M, Spencer AE (2015). Right cot, right place, right time: improving the design and organisation of neonatal care networks. Health service delivery research, 3(20). Full text. Vasilakis C, Chaussalet T, Pitt M (2015). The 7th IMA international conference on quantitative modelling in the management of health and social care: IMA health 2013 special issue. Health Care Management Science, 18(2), 107-109. Abstract. Article has an altmetric score of 1 Chalk D, Pitt M (2015). The impact of minor injury unit closures on travel time and attendances. British Journal of Health Care Management, 21(5), 241-246. Abstract. Chalk D, Pitt M, Stein K (2014). Cost-effectiveness of bevacizumab for diabetic macular oedema. British Journal of Health Care Management, 20(12), 585-593. Abstract. Monks T, Pearson M, Pitt M, Stein K, James MA (2014). Evaluating the impact of a simulation study in emergency stroke care. Operations Research for Health Care Abstract. Article has an altmetric score of 10 Monks TMW, Pitt M, Stein K, James MA (2014). Hyperacute Stroke Care and NHS England's Business Plan. BMJ: British Medical Journal Author URL. Article has an altmetric score of 4 Monks T, Pitt M, Stein K, James MA (2014). Hyperacute stroke care and NHS England's business plan: Computer simulation, coupled with high quality data, can help in decision making. BMJ (Online), 348 Article has an altmetric score of 4 Pitt M (2014). Systems Analysis Tools for Better Health Care Delivery. INTERFACES, 44(4), 434-435. Author URL. Pearson M, Monks T, Gibson A, Allen M, Komashie A, Fordyce A, Harris-Golesworthy F, Pitt MA, Brailsford S, Stein K, et al (2013). Involving patients and the public in healthcare operational research-The challenges and opportunities. Operations Research for Health Care Pearson M, Monks T, Gibson A, Allen M, Komashie A, Fordyce A, Harris-Golesworthy F, Pitt MA, Brailsford S, Stein K, et al (2013). Involving patients and the public in healthcare operational research-The challenges and opportunities. Operations Research for Health Care, 2 Abstract. Article has an altmetric score of 10 Brailsford SC, Bolt TB, Bucci G, Chaussalet TM, Connell NA, Harper PR, Klein JH, Pitt M, Taylor M (2013). Overcoming the barriers: a qualitative study of simulation adoption in the NHS. Journal of the Operational Research Society, 64(2), 157-168. Abstract. Chalk D, Pitt M, Vaidya B, Stein K (2012). Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy?. Diabetes Care, 35(8), 1663-1668. Abstract. Author URL. Article has an altmetric score of 10 Rogers G, Hoyle M, Thompson Coon J, Moxham T, Liu Z, Pitt M, Stein K (2012). Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation. Health Technol Assess, 16(22), 1-410. Abstract. Author URL. Full text. Article has an altmetric score of 3 Monks T, Pitt M, Stein K, James M (2012). Maximizing the population benefit from thrombolysis in acute ischemic stroke: a modeling study of in-hospital delays. Stroke, 43(10), 2706-2711. Abstract. Author URL. Article has an altmetric score of 3 Pitt M, Monks T, Agarwal P, Worthington D, Ford GA, Lees KR, Stein K, James MA (2012). Will delays in treatment jeopardize the population benefit from extending the time window for stroke thrombolysis?. Stroke, 43(11), 2992-2997. Abstract. Author URL. Article has an altmetric score of 2 Pitt M, Crathorne L, Moxham T, Bond M, Hyde C (2010). Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis. Health Technol Assess, 14(Suppl. 2), 41-46. Abstract. Author URL. Pitt M, Crathorne L, Moxham T, Bond M, Hyde C (2010). Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis. Health technology assessment (Winchester, England), 14(Suppl. 2), 41-46. Abstract.